ALPS Medical Breakthroughs ETF Rating $29.91 +0.27 (+0.91%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.90Holdings in SBIO have an aggregate rating of Moderate Buy based on 477 analyst ratings issued in the past year covering 50 companies (87.1% of the portfolio).SBIO Aggregate Price Target$29.91High Prediction$29.91Average Prediction$29.91Low Prediction$29.91Holdings in SBIO have an aggregate price target of $29.91 and a range of $29.91 to $29.91 covering 50 companies (87.1% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy32 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.66%VRNAVerona Pharma$72.73+0.7%2.7378 of 5 stars3.11$81.50 12.1%9Earnings ReportAnalyst ForecastInsider TradeShort Interest ↓Analyst RevisionNews CoveragePositive News4.43%AXSMAxsome Therapeutics$112.210.0%4.8478 of 5 stars3.00$169.87 51.4%16Upcoming EarningsAnalyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive News4.27%ALKSAlkermes$31.78+3.9%4.1827 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage3.79%RYTMRhythm Pharmaceuticals$64.01+0.3%3.7867 of 5 stars3.00$74.92 17.0%13Upcoming EarningsInsider TradeNews CoveragePositive News3.56%PTCTPTC Therapeutics$49.95+0.9%3.9347 of 5 stars2.53$63.92 28.0%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News3.08%RNAAvidity Biosciences$32.20-1.5%2.7114 of 5 stars3.00$66.69 107.1%13Upcoming EarningsInsider TradePositive News3.06%ZLABZai Lab$31.18+0.1%2.4628 of 5 stars2.75$47.37 51.9%4Upcoming EarningsNews Coverage2.92%AKROAkero Therapeutics$44.87-1.0%3.8022 of 5 stars3.00$76.29 70.0%9Upcoming EarningsNews CoveragePositive News2.92%MRUSMerus$44.19-2.8%3.4157 of 5 stars3.13$85.31 93.0%16Upcoming EarningsShort Interest ↓Analyst RevisionNews Coverage2.86%PTGXProtagonist Therapeutics$45.51+1.2%3.4858 of 5 stars3.00$65.44 43.8%9Upcoming EarningsNews CoveragePositive News2.64%CRNXCrinetics Pharmaceuticals$33.76+0.7%3.7899 of 5 stars2.92$73.00 116.2%13Upcoming EarningsNews CoveragePositive News2.42%XENEXenon Pharmaceuticals$38.28+0.5%2.6377 of 5 stars3.00$56.78 48.3%10Upcoming EarningsAnalyst DowngradeOptions VolumeNews CoveragePositive NewsHigh Trading Volume2.36%ACADACADIA Pharmaceuticals$14.91+2.3%4.2579 of 5 stars2.50$23.87 60.1%16Upcoming EarningsAnalyst Revision2.29%MLTXMoonLake Immunotherapeutics$42.32+2.1%1.7404 of 5 stars3.00$80.50 90.2%8Upcoming EarningsAnalyst ForecastNews Coverage2.02%FOLDAmicus Therapeutics$6.67-0.1%4.2449 of 5 stars2.70$16.22 143.2%10Analyst ForecastNews CoverageHigh Trading Volume2.01%VCELVericel$38.95+2.7%2.3842 of 5 stars3.00$60.86 56.2%7Upcoming EarningsNews CoveragePositive News1.93%DNLIDenali Therapeutics$16.44+2.4%4.0803 of 5 stars3.06$37.57 128.5%17Upcoming EarningsPositive NewsGap Up1.81%TARSTarsus Pharmaceuticals$47.36-5.8%2.2677 of 5 stars3.00$64.67 36.5%7Earnings ReportUpcoming EarningsAnalyst ForecastNews CoveragePositive NewsGap Down1.81%MIRMMirum Pharmaceuticals$43.69+0.6%4.2674 of 5 stars3.09$58.20 33.2%11Upcoming EarningsNews CoveragePositive News1.65%NAMSNewAmsterdam Pharma$20.033.1892 of 5 stars3.00$43.33 116.3%6Positive News1.55%AGIOAgios Pharmaceuticals$30.10-2.7%4.2242 of 5 stars2.56$56.00 86.0%9Earnings ReportAnalyst UpgradeAnalyst RevisionNews Coverage1.52%GLPGGalapagos$27.34+2.1%0.6751 of 5 stars1.50$25.33 -7.3%8Short Interest ↓Gap Up1.50%CGONCG Oncology$29.05+4.7%2.0279 of 5 stars3.00$57.70 98.6%12Upcoming EarningsAnalyst ForecastNews CoverageGap Up1.49%BCRXBioCryst Pharmaceuticals$8.93+2.5%4.4965 of 5 stars2.88$16.13 80.6%8Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.44%APGEApogee Therapeutics$40.12+2.3%2.2583 of 5 stars3.00$92.17 129.7%6News CoveragePositive News1.39%IRONDisc Medicine$49.51-0.3%2.3911 of 5 stars3.09$93.80 89.5%11Upcoming EarningsNews CoveragePositive News1.38%IDYAIDEAYA Biosciences$20.93+2.2%3.7354 of 5 stars2.93$53.58 156.0%15Upcoming EarningsPositive News1.35%MNKDMannKind$5.00+1.0%3.1389 of 5 stars3.22$9.56 91.3%9Upcoming EarningsNews CoveragePositive News1.32%VERAVera Therapeutics$25.31+6.6%2.9929 of 5 stars3.20$64.67 155.5%10Upcoming EarningsPositive NewsHigh Trading Volume1.30%IMCRImmunocore$30.46+1.0%3.075 of 5 stars2.45$59.44 95.2%11Upcoming EarningsPositive News1.21%CLDXCelldex Therapeutics$20.66-0.2%1.8483 of 5 stars2.90$55.30 167.7%10Upcoming EarningsNews CoveragePositive NewsGap Up1.17%EWTXEdgewise Therapeutics$16.91+1.4%3.1382 of 5 stars2.78$40.22 137.9%9Upcoming EarningsAnalyst ForecastShort Interest ↑News CoveragePositive News1.12%LQDALiquidia$15.83+13.2%2.9068 of 5 stars3.11$26.63 68.2%9News CoveragePositive NewsHigh Trading Volume1.08%GPCRStructure Therapeutics$27.09-0.9%2.4264 of 5 stars3.00$78.63 190.2%9Upcoming EarningsAnalyst ForecastNews CoverageGap Up1.04%VRDNViridian Therapeutics$13.62-0.9%1.1941 of 5 stars2.75$35.70 162.1%12Upcoming EarningsPositive News1.01%AUPHAurinia Pharmaceuticals$8.21+0.1%2.6769 of 5 stars3.00$11.50 40.1%20.96%NVAXNovavax$6.413.6362 of 5 stars2.43$18.00 180.8%7Upcoming Earnings0.81%RCUSArcus Biosciences$9.12+5.8%2.3828 of 5 stars3.00$28.38 211.1%10Upcoming EarningsNews CoveragePositive News0.76%VIRVir Biotechnology$6.16+1.3%2.8539 of 5 stars2.86$33.57 445.0%7News Coverage0.75%NTLAIntellia Therapeutics$8.84+2.3%4.614 of 5 stars2.65$36.68 315.0%20Upcoming Earnings0.72%AVXLAnavex Life Sciences$9.36+0.5%3.9294 of 5 stars3.33$44.00 370.1%3Upcoming EarningsNews Coverage0.69%DAWNDay One Biopharmaceuticals$7.93+4.1%2.7992 of 5 stars3.13$32.29 307.1%8Upcoming EarningsNews Coverage0.67%PHVSPharvaris$18.37+2.9%2.2262 of 5 stars3.00$39.00 112.3%4Analyst ForecastAnalyst RevisionNews Coverage0.65%NUVBNuvation Bio$2.46+8.4%3.7622 of 5 stars3.17$7.83 218.4%6Upcoming EarningsNews CoveragePositive NewsHigh Trading Volume0.65%XNCRXencor$11.26+3.7%3.1098 of 5 stars3.13$32.86 191.8%8Upcoming EarningsAnalyst ForecastNews Coverage0.63%MLYSMineralys Therapeutics$15.42+3.1%2.4586 of 5 stars3.00$33.00 114.0%3Upcoming EarningsShort Interest ↑News Coverage0.62%AVBPArriVent BioPharma$21.30+1.0%1.1199 of 5 stars3.17$39.00 83.1%6Short Interest ↑News Coverage0.61%IMNMImmunome$8.85-0.1%2.6675 of 5 stars3.00$25.33 186.3%6News CoveragePositive News0.60%DNTHDianthus Therapeutics$21.701.7168 of 5 stars3.22$54.33 150.4%9Upcoming EarningsNews CoveragePositive News0.58%PRAXPraxis Precision Medicines$40.24+5.7%3.2507 of 5 stars2.78$123.33 206.5%9Earnings ReportAnalyst ForecastNews Coverage This page (NYSEARCA:SBIO) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBIO Stock Free SBIO Stock Alerts